Board of Directors Committee Composition
= Chair = Member = Independent Director
|Jay M. Moyes|
|Hans Klingemann, M.D., Ph.D|
Stock transaction information provided by EDGAR Online. Osiris Therapeutics, Inc. makes no representations or warranties with respect to the information contained herein and takes no responsibility for supplementing, updating, or correcting any such information. This listing does not include non-monetary transactions, such as stock option grants or shares purchased through the employee stock purchase plan. For recent transactions including non-monetary transactions, see our Section 16 SEC filings page.
Contact the Board
You can contact Osiris Therapeutics Board of Directors to provide comments, to report concerns, or to ask a question, at the following address.
Osiris Therapeutics, Inc.
7015 Albert Einstein Drive
Columbia, MD 21046
You may submit your concern anonymously or confidentially by postal mail. You may also indicate whether you are a shareholder, customer, supplier, or other interested party.
Communications are distributed to the Board, or to any individual directors as appropriate, depending on the facts and circumstances outlined in the communication. In that regard, the Osiris Therapeutics, Inc. Board of Directors has requested that certain items which are unrelated to the duties and responsibilities of the Board should be excluded, such as:
- Product complaints
- Product inquiries
- New product suggestions
- Resumes and other forms of job inquiries
- Business solicitations or advertisements
In addition, material that is unduly hostile, threatening, illegal or similarly unsuitable will be excluded, with the provision that any communication that is filtered out must be made available to any non-management director upon request.
You may also communicate online with our Board of Directors as a group.